戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lized circulating insulin by injection of an insulin antibody.
2 proterenol and PD98059, but not those of the insulin antibody.
3          None of the infants developed serum insulin antibodies.
4 rformed by electrophoretically sampling anti-insulin antibody (Ab), fluorescein isothiocyanate-labele
5 the variable regions of a high-affinity anti-insulin antibody as IgG and IgM.
6 a, weight, lipid levels, pulmonary function, insulin antibody binding, and adverse events.
7 cein isothiocyanate-labeled insulin and anti-insulin antibody for 60 s.
8 cein isothiocyanate-labeled insulin and anti-insulin antibody for a competitive immunoassay.
9 ation between pulmonary function changes and insulin antibody generation.
10            In patients with type 1 diabetes, insulin antibodies (IA), altering the pharmacokinetics o
11 is is shown for selective sensing of an anti-insulin antibody in the presence of its IgG isotype.Effi
12 rituximab not only blocks the acquisition of insulin antibodies induced by insulin administration and
13 of T cells specific for deamidated peptides, insulin antibody levels at diagnosis, and duration of di
14                                 By contrast, insulin antibody levels remained low for the first 2 wk
15          Spirometry tests were conducted and insulin antibody levels were measured throughout the stu
16 f MNP-serum insulin conjugate to the surface insulin-antibody on PGE/MWNT/Py electrodes.
17                                       Either insulin antibody or isoproterenol treatment induced the
18 ne D(3) receptor, dopamine D(2) receptor, or insulin antibodies, suggesting that loss of endocrine do
19 various insulin analogs to a monoclonal anti-insulin antibody, thus providing a comparison with the p
20 tor memory cells is directly correlated with insulin antibody titers, suggesting insulin-specific T-
21 islet supernatant was reduced by 75% by anti-insulin antibody treatment.
22 te electrodes (PGE/MWNT/Py) to which an anti-insulin antibody was covalently attached.
23 oglycemia, mild weight gain, mild cough, and insulin antibodies were more frequent with inhaled insul